These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20236628)

  • 1. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
    Brown DM
    Cell Immunol; 2010; 262(2):89-95. PubMed ID: 20236628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
    Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic CD4(+) T cells in viral immunity.
    Soghoian DZ; Streeck H
    Expert Rev Vaccines; 2010 Dec; 9(12):1453-63. PubMed ID: 21105780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.
    Binder D; Kündig TM
    J Immunol; 1991 Jun; 146(12):4301-7. PubMed ID: 1710246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
    J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.
    Ahrends T; Bąbała N; Xiao Y; Yagita H; van Eenennaam H; Borst J
    Cancer Res; 2016 May; 76(10):2921-31. PubMed ID: 27020860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
    Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
    J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK; Katzenstein D; Moses LE; Merigan TC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
    Liu J; Roederer M
    Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene.
    Egan MA; Pavlat WA; Tartaglia J; Paoletti E; Weinhold KJ; Clements ML; Siliciano RF
    J Infect Dis; 1995 Jun; 171(6):1623-7. PubMed ID: 7769304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
    J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.